Cohen & Steers Inc (CNS) Dividend Safety Gauge & 10-Year DRIP Compounder

$72.48 -0.59% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $72.27

Cohen & Steers Inc (CNS) carries a Roarable Rating of D- (Sell) with 43/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- β€’ SELL / AVOID Cap $3.73B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CNS Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is CNS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Cohen & Steers Inc (NYSE: CNS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $72.48 (-0.59% 1D, market cap $3.73B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 1096 tracked Financials issuers, CNS ranks #839 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does CNS compare to LAZ and FHI in the Financials sector?
β–Ό

Within the Financials sector (Investment Managers), CNS carries a Roarable D- (43/100 RQD), trailing P/E of 24.5x, gross margin of β€”, and ROIC of 33.7%. By comparison, LAZ (Lazard Inc.) holds a C- grade (59/100 RQD, P/E 16.3x, ROIC 24.4%, cap $3.75B) and FHI (Federated Hermes Inc.) posts a B grade (74/100 RQD, P/E 10.7x, ROIC 39.8%, cap $4.37B). Among the 5-stock peer group, HTGC leads on earnings multiple (9.3x) while AAMI leads on capital efficiency (40.3% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CNS?
β–Ό

Per CNS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001284812), Cohen & Steers Inc generated $0 in revenue, $153.2M in net income, and -$126.4M in free cash flow against $876.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $72.26 (-0.30%)🧬 Dilution Drag (+1.36% YoY Shares)βš™οΈ Cash Engine: 9/20 (D) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (43/100 Β· D-) historically underperformed SPY in 71% of rolling 90-day windows (-6.7% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D-
025507510043
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- Β· Rk D
Cash (9)Whales (9)SEC (10)Macro (8)CEO (7)
Each axis scored 0–20
12M PRICE TARGET CONE-6.7% Base Target
$91 Bull$68 Base$53 Bear
πŸ“¬ FREE CNS RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for CNS)Realized 20D OHLCV Swing Band: Β±6.9%
Deterministic 5-Pillar Attribution (43/100 Composite)
πŸ” WHY CNS SCORES 43/100 (D-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 2/9

β–² #2 Bullish Driver: Cash Engine Quality+9/20 pts (21% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution7/20 pts (-13 pt drag)

Dilution Drag (+1.36% YoY Shares) & executive Form 4 sales trim 13 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
35
Grade E$68.86+4.6% Next Q
Q2 (-2Q)
38
Grade E$72.03-1.7% Next Q
Q3 (-1Q)
40
Grade D$70.79+2.4% Next Q
Current
43
Grade D-$72.48-6.7% Hist 90D Ξ±
Trajectory: E (35) β†’ D- (43)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a CNS Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While CNS currently carries a cautious 43/100 (D-) rating due to Insider Conviction & Share Dilution (7/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($73.86) and Max Pain ($76.10) forces dealer call-delta covering toward $90.89.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CNSβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œCNS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
CASH DIVIDEND + BUYBACK YIELD
3.99% Total Yield
3.39% Cash ($2.46/yr) + 0.6% Buybacks
PAYOUT SAFETY SPEEDOMETER
41/100 β€’ ELEVATED PAYOUT WATCH
FREE CASH FLOW PAYOUT RATIO
96% of FCF
8 consecutive years of payout growth
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (8.9% EST. ANNUAL)

$10,000 Compounded Over 10 Years β†’ $23,457

Est. Year-10 Shareholder Yield: $936/yr
$10.9K
Yr 1
$11.9K
Yr 2
$12.9K
Yr 3
$14.1K
Yr 4
$15.3K
Yr 5
$16.7K
Yr 6
$18.2K
Yr 7
$19.8K
Yr 8
$21.5K
Yr 9
$23.5K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CNS)

  • βœ“Walkthrough of CNS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CNS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +6.17%πŸ“ HORIZONTAL RANGE
2026-11-03O $72.91H $72.91L $72.48C $72.48VOL 263.8K
RES: $84.85SUP: $63.59SMA50: $73.86SMA200: $72.04
$88.06$81.83$75.61$69.38$63.15RES $84.85SUP $63.59$72.482026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CNS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
18.2%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CNS today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for CNS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CNS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CNS)

1. Head-to-Head Financials Peer Comparison (CNS vs. LAZ, FHI, AAMI, HTGC)

Industry: Investment Managers (79 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Cohen & Steers Inc (CNS) ranks #839 by composite RQD confidence (43/100, grade D-) and #319 by equity capitalization ($3.73B). Within this direct 5-issuer industry benchmark cohort, HTGC leads on earnings valuation at 9.3x trailing P/E, while AAMI leads on capital efficiency and profitability with 40.3% ROIC and β€” gross margin. FHI currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with CNS at 43/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CNS ACTIVE
Cohen & Steers Inc
D- 43/100 24.5x β€” 33.7% -0.59% $3.73B Benchmark Subject
LAZ
Lazard Inc.
C- 59/100 16.3x β€” 24.4% -3.01% $3.75B /laz-vs-cns β†’
FHI
Federated Hermes Inc.
B 74/100 10.7x β€” 39.8% +0.81% $4.37B /fhi-vs-cns β†’
AAMI
Acadian Asset Management Inc.
D 50/100 40.5x β€” 40.3% -2.63% $3.16B /aami-vs-cns β†’
HTGC
Hercules Capital Inc.
D- 42/100 9.3x β€” 15.3% -1.83% $3.14B /htgc-vs-cns β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001284812

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cohen & Steers Inc (CNS) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $153.2M, operating cash flow of -$120.4M, and free cash flow of -$126.4M (-248.7% YoY). On the balance sheet, CNS closed FY2025 with $876.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $0 $153.2M -$120.4M -$126.4M $876.7M β€”
FY2024 (FY) 2024-12-31 $0 $151.3M $96.7M $85.0M $812.4M β€”
FY2023 (FY) 2023-12-31 $0 $129.0M $172.0M $172.0M β€” β€”

3. CNS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CNS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Cohen & Steers Inc (NYSE: CNS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $72.48 (-0.59% 1D, market cap $3.73B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 1096 tracked Financials issuers, CNS ranks #839 in composite RQD confidence.

How does CNS compare to LAZ and FHI in the Financials sector?

Within the Financials sector (Investment Managers), CNS carries a Roarable D- (43/100 RQD), trailing P/E of 24.5x, gross margin of β€”, and ROIC of 33.7%. By comparison, LAZ (Lazard Inc.) holds a C- grade (59/100 RQD, P/E 16.3x, ROIC 24.4%, cap $3.75B) and FHI (Federated Hermes Inc.) posts a B grade (74/100 RQD, P/E 10.7x, ROIC 39.8%, cap $4.37B). Among the 5-stock peer group, HTGC leads on earnings multiple (9.3x) while AAMI leads on capital efficiency (40.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CNS?

Per CNS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001284812), Cohen & Steers Inc generated $0 in revenue, $153.2M in net income, and -$126.4M in free cash flow against $876.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CNS trading relative to its 50-day, 200-day, and 52-week technical levels?

CNS last traded at $72.48 (-0.59% on volume of 263,798 shares), positioning the stock -1.87% below its 50-day simple moving average ($73.86) and +0.61% above its 200-day simple moving average ($72.04). Across its 52-week range of $58.39 to $86.56, CNS sits at the 50.0% percentile with a 14-day RSI of 51.9 (NEUTRAL RANGE) and an implied next-earnings move of Β±6.9% ($67.48 to $77.48).

CNS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Does CNS pay a dividend and is it safe?

Cohen & Steers Inc (CNS) offers a 3.39% cash dividend yield ($2.46 annualized) and 3.99% total shareholder yield including buybacks. Roarable rates its payout coverage as ELEVATED PAYOUT WATCH.

ROARABLE RATING BRIEF β€’ RQD 43/100 (D-) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

CNS β€” Cohen & Steers Inc: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:22:52Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, CNS scores 42 out of 100, a letter grade of D-, with the verdict "Roarable Sell β€” Vulnerable Balance Sheet & Flow." Across the five pillars:

  • Fundamental Cash Engine: 9 / 20. Per the RQD rating, ROIC is 33.7% but FCF yield is -3.37%. For an investor, a high return on invested capital paired with negative free-cash-flow yield signals that accounting profitability is not translating into cash available to shareholders in the current period.
  • Whale 13F Flow: 8 / 20. The RQD rating describes this pillar as institutional accumulation and options positioning. The underlying 13F and options detail is not itemized in the source data, so the sub-score reflects a weak institutional tailwind without specific holder evidence.
  • Insider Conviction: 7 / 20. Per the RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Insider evidence is the second-weakest signal in the rating, meaning insiders are not supplying meaningful conviction support.
  • Macro Regime Fit: 8 / 20. Per the RQD rating, beta is 1.0 and sector sensitivity is a drag. An investor should expect CNS to move in line with the broad market, with no defensive cushion from its profile.
  • Forensic Balance Sheet: 10 / 20. Per the RQD rating, Altman Z is 2.5, Piotroski F is 2/9, and Debt/Equity is 0.5. The Piotroski score of 2/9 indicates weak fundamental quality across the standard checks, which is the most important forensic warning in the rating.

Valuation tradeoffs: per the market data, the stock trades at a P/E (TTM) of 24.5, a Forward P/E of 22.8, and an EV/EBITDA of 19.7. These multiples price in continued earnings growth that the weak Piotroski reading and negative FCF yield do not clearly support. Upside drivers would require cash conversion to improve; the rating suggests that is the central unresolved condition.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
$72.91$3.75B24.522.819.72.983.39%1.0$58.39 - $86.5633.7%

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$0.0M$177.7M$153.2MN/A$-126.4M$145.5MN/A
FY 2024$0.0M$172.9M$151.3MN/A$85.0M$183.0MN/A
FY 2023$0.0M$164.5M$129.0MN/A$172.0MN/AN/A

Per the SEC financials, operating income rose from $164.5M (FY 2023) to $177.7M (FY 2025) and net income rose from $129.0M to $153.2M over the same span, while FCF moved from $172.0M to $85.0M to $-126.4M. Reported gross, operating, and net margins in the market data are each 0%, which conflicts with the reported income figures and cannot be reconciled from the source data. Per the market data, ROIC is 33.7%. Per the RQD rating, Altman Z is 2.5 and Piotroski F is 2/9. Debt/Equity is 0.5 per the RQD rating; the debt figures in the financials are N/A. Balance sheet posture is weakened by the FY 2025 negative FCF and the declining cash balance from $183.0M to $145.5M.

Recent Catalysts & News Wire Analysis

  • RISK WATCH (RED): Investing.com South Africa reported a stock move of over 5% on strong inflows alongside a Q3 miss. Per the news wire, this item is flagged as a risk watch.
  • MARKET WIRE (YELLOW): Yahoo Finance reported that Assets Under Management declined in September. This is the most direct fundamental headwind in the wire.
  • CATALYST (GREEN): Multiple outlets (Yahoo Finance, TradingView) reported that Q3 2026 beat on revenue.
  • CATALYST (GREEN): GuruFocus reported a share surge of 5.3% and cited a GF Score of 8.
  • MARKET WIRE (YELLOW): Seeking Alpha published a note stating the stock is "Not Great With Upwards Yield Curve Movements."

Per the Butterfly Supply-Chain Graph, the supply chain is NONE, with no butterfly links and no proprietary signals.

Open Questions

  • What explains the reported $0.0M revenue line while net income is positive, and why are the gross, operating, and net margins reported as 0%?
  • What drove the move from positive FY 2024 FCF of $85.0M to negative FY 2025 FCF of $-126.4M, and is it a timing effect or structural?
  • What are the debt levels behind the 0.5 Debt/Equity figure, given that the debt field is N/A in every period?
  • What is the size and direction of the September AUM decline, and how does it affect the sustainability of the reported Q3 revenue beat?
  • What specific institutional and insider transactions sit behind the whale-flow and insider-conviction pillar scores?

CNS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Cohen & Steers Inc (CNS) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to CNS Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CNS Bull vs. Bear Conversation Board β€” What's Your Call at $72.48?

πŸ‚ 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CNS 🐻 67% BEARISH CONVICTION
1. Pick Your Side on CNS:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $64.16 (-12.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is CNS (D- β€’ RQD 42/100) a Buy at $72.91?

Welcome to the CNS (Cohen & Steers Inc) Roar Pit. Current RQD Composite is 42/100 (Roarable Sell β€” Vulnerable Balance Sheet & Flow) in Investment Managers. Bulls point to capital efficiency (33.7% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $58.33 (-20.0%)
Spot @ $72.91

Pump the brakes on CNS β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CNS, but look at what you are paying: 24.5x trailing P/E with tightening sector spreads. Unless Cohen & Steers Inc expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $89.68 (+23.0%)
Spot @ $72.91

CNS cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CNS, the market is fixating on short-term headline noise in Investment Managers and ignoring the balance sheet and cash flow trajectory. At $72.91 (52-wk range $58.39 - $86.56), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%